Cargando…
Pharmacological Augmentation in Unipolar Depression: A Guide to the Guidelines
BACKGROUND: Pharmacological augmentation is a recommended strategy for patients with treatment-resistant depression. A range of guidelines provide advice on treatment selection, prescription, monitoring and discontinuation, but variation in the content and quality of guidelines may limit the provisi...
Autores principales: | Taylor, Rachael W, Marwood, Lindsey, Oprea, Emanuella, DeAngel, Valeria, Mather, Sarah, Valentini, Beatrice, Zahn, Roland, Young, Allan H, Cleare, Anthony J |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7710919/ https://www.ncbi.nlm.nih.gov/pubmed/32402075 http://dx.doi.org/10.1093/ijnp/pyaa033 |
Ejemplares similares
-
Characterising the severity of treatment resistance in unipolar and bipolar depression
por: Taylor, Rachael W., et al.
Publicado: (2021) -
Patient perspectives of lithium and quetiapine augmentation treatment in treatment-resistant depression: A qualitative assessment
por: McKeown, Lucas, et al.
Publicado: (2022) -
Online mood monitoring in treatment-resistant depression: qualitative study of patients' perspectives in the NHS
por: Incecik, Emma, et al.
Publicado: (2020) -
Systematic review and meta-analysis of augmentation and combination
treatments for early-stage treatment-resistant depression
por: Scott, Fraser, et al.
Publicado: (2022) -
Cortisol levels in unmedicated patients with unipolar and bipolar major depression using hair and saliva specimens
por: Herane-Vives, Andrés, et al.
Publicado: (2020)